NeuroPace Inc - Common Stock, $0.01 par value (NPCE)

CUSIP: 641288105

Q2 2022 13F Holders as of 30 Jun 2022

Security type / class
Equity / Common Stock, $0.01 par value
Total 13F shares
18,426,044
Total 13F value
$91,207,000
Holder snapshot 6 signals
Share change
+216,997
SEC-reported price per share
$4.95
Number of holders
26
Value change
-$26,340
Number of buys
12
Number of sells
26
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
34,087,924

Security key

641288105

Report period

Q2 2022

Institutions

26

Top holders

10

NPCE full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2022 Previous quarter: Q1 2022 NeuroPace Inc SEC filings NeuroPace Inc company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of NPCE - NeuroPace Inc - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
KCK LTD.
Disclosed value leader
KCK LTD.
Comparable rows
15/15
Latest evidence
31 Mar 2022
13F Lead comparable stake: 16% Showing 1-6 of 15 holder rows.

Quick read

KCK LTD. leads the comparable SEC ownership view at 16%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens KCK LTD.'s linked filing trail.
Comparable ownership Top 5
KCK LTD. 16%
ORBIMED ADVISORS LLC 12%
Soleus Capital Management, L.P. 6.8%
FMR LLC 4.1%
MORGAN STANLEY 3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
KCK LTD.
13F
Company
13F
16%
$46,149,000
5,621,111 shares
 — 31 Mar 2022
ORBIMED ADVISORS LLC
13F
Company
13F
12%
$32,941,000
4,012,281 shares
 — 31 Mar 2022
Soleus Capital Management, L.P.
13F
Company
13F
6.8%
$19,080,000
2,324,003 shares
 — 31 Mar 2022
FMR LLC
13F
Company
13F
4.1%
$11,554,000
1,407,306 shares
 — 31 Mar 2022
MORGAN STANLEY
13F
Company
13F
3%
$8,504,000
1,035,784 shares
 — 31 Mar 2022
AMERICAN CENTURY COMPANIES INC
13F
Company
13F
1.6%
$4,390,000
534,664 shares
 — 31 Mar 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
26
Shares
18,426,044
Rows available
26
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
37
Q2 2022 holders
26
Holder diff
-11
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 value Q2 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .